课题基金 / 基金详情

Toll-like receptor expression level on circulating monocyte in cardiomyopathy

Toll-like receptor expression level on circulating monocyte in cardiomyopathy
心肌病循环单核细胞Toll样受体表达水平
批准号:
21590905
负责人:
HAMASAKI Syuichi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We hypothesized that Toll-like receptor 2(TLR2) expression level on monocytes can be useful as a marker of inflammatory activity in inflammatory cardiomyopathy as a new concept which choronic myocarditis evolves to dilated cardiomyopathy. Thus, we tried to validate our hypothesis by comparing pathological findings of species derived from myocardium with TLR2 expression level on monocytes, but our trial ended up in failure. We could not either verify the usefulness of Toll-like receptor 2 expression level on monocytes for establishing the diagnostic criteria of dilated cardiomyopathy as an inflammatory cardiomyopathy. Although the patients who were diagnosed as cardiac sarcoidosis showed extremely higher level of TLR2, which may suggest that TLR2 expression level on monocytes is identified as a significant contributor for cardiac sarcoidosis. Therefore, high TLR2 expression level on monocytes may be an independent risk factor for cardiac sarcosidosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
シンポジウム21,循環器疾患の成因における慢性炎症の意義:Modulation of Toll-like receptor 2 on chronic inflammation in patients with atherosclerosis and atrial fibrillation
研讨会21,慢性炎症在心血管疾病发病机制中的意义:Toll样受体2对动脉粥样硬化和心房颤动患者慢性炎症的调节
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Suzuki T, Tomiyama H, Higashi Y, 山部浩茂, 折原弘治]
通讯作者: 折原弘治
Reevaluation of quantitative flow cytometric analysis for TLR2 on monocytes using F(ab')(2) fragments of monoclonal antibodies
使用单克隆抗体 F(ab)(2) 片段重新评估单核细胞上 TLR2 的定量流式细胞术分析
DOI: 10.1002/cyto.a.21000
发表时间: 2011
期刊: Cytometry A
影响因子: --
作者: [Lo Li-Wei, Satoshi Higa, et al., 大場隆一郎]
通讯作者: 大場隆一郎
Key note lecture, High expression level of Toll-like receptor 2 on monocytes as a new risk factor for arteriosclerotic disease
主题演讲,单核细胞上Toll样受体2的高表达水平作为动脉硬化疾病的新危险因素
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Hamasaki S, Orihara K, Kuwahata S, Fujita S, Tei C.]
通讯作者: Tei C.
Role of Infectious Inflammation for Atherogenesis : Toll-like Receptor 2 vs. C-reactive Protein.
感染性炎症对动脉粥样硬化形成的作用:Toll 样受体 2 与 C 反应蛋白。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [So Kuwahata, Shoji Fujita, Koji Orihara, Shuichi Hamasaki, Tetsuro Kataoka, Keishi Saihara, Sanemasa Ishida, Hitoshi Ichiki, Naoya Oketani, Yuichi Ninomiya, Hideki Okui, Ryutaro Oba, Hiroyuki Hirai, Kinya Nagata, Chuwa Tei]
通讯作者: Chuwa Tei
14
    国内基金
    海外基金
    基于液体活检基因组学构建晚期乳腺癌内科精准靶向治疗预测模型的研究
    • 批准号:
      2025JJ50153
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      胡哲煜
    • 依托单位:
    临床药师干预程度对心血管内科预防性使用质子泵抑制剂合理性的影响研究
    • 批准号:
      2025A01046
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      郑小棵
    • 依托单位:
    经内科胸腔镜在不同直径肺大疱穿刺、固化及APC 治疗疗效 差异及安全性相关因素的研究
    • 批准号:
      2024JJ9574
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      何正兵
    • 依托单位:
    基于丁氏内科学术思想治疗帕金森病合并睡眠障碍的临床实践及创新研究